Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
IMIDAZOPYRIDINE COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/244634
Kind Code:
A1
Abstract:
The present invention provides an imidazopyridine compound and use thereof. Specifically, the present invention provides a compound represented by formula I, a tautomer, a stereoisomer, a hydrate, a solvate, a pharmaceutically acceptable salt or a prodrug thereof, a preparation method therefor, and use thereof in preparing medicaments.

More Like This:
WO/2012/128709A PHARMACEUTICAL COMPOSITION COMPRISING A HDAC INHIBITOR AND A STEROID AND THE USE THEREOF.
WO/2022/188823TRICYCLIC HPK1 INHIBITOR AND USE THEREOF
WO/2023/057613BENZIMIDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF A HISTIOCYTOSIS OR A CRANIOPHARYNGIOMA
Inventors:
ZHANG XUEJUN (CN)
ZANG YANG (CN)
LI LIE (CN)
YANG CHENGBING (CN)
Application Number:
PCT/CN2021/098296
Publication Date:
December 09, 2021
Filing Date:
June 04, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
WUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY (CN)
International Classes:
A61K31/437; C07D471/04; A61K31/5377; A61P11/00; A61P11/14; A61P13/00; A61P13/02; A61P13/08; A61P13/10; A61P15/00; A61P25/06; A61P29/00
Domestic Patent References:
WO2020174283A12020-09-03
Foreign References:
CN112409331A2021-02-26
CN105246888A2016-01-13
Other References:
GABRIELLA MARUCCI, DIEGO DAL BEN, MICHELA BUCCIONI, ALEIX MARTí NAVIA, ANDREA SPINACI, ROSARIA VOLPINI, CATIA LAMBERTUCCI: "Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications", EXPERT OPINION ON THERAPEUTIC PATENTS, vol. 29, no. 12, 2 December 2019 (2019-12-02), GB , pages 943 - 963, XP055704067, ISSN: 1354-3776, DOI: 10.1080/13543776.2019.1693542
Attorney, Agent or Firm:
TSINGYIHUA INTELLECTUAL PROPERTY LLC (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: METHOD FOR SENDING SCHEDULING REQUEST AND TERMINAL

Next Patent: METABOLITE AT POSITION 21 OF FENLEAN, AND PREPARATION AND USE THEREOF